Supplier profile
GlaxoSmithKline GmbH & Co. KG
Every public-sector award we hold for this supplier, across Germany, from 25 Oct 2011 to 29 Jul 2026.
Awards won
84
all time
Attributed value
€1.9m
49 shared, unvalued
Buyers
28
public bodies
Active
2011–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 13 | not attributable |
| AOK Baden-Württemberg | 11 | not attributable |
| GWQ ServicePlus AG | 10 | €1 |
| Bundesamt für Ausrüstung, Informationstechnik und Nutzung der Bundeswehr | 7 | €0 |
| IKK classic | 7 | €1.9m |
| Techniker Krankenkasse | 4 | €1 |
| AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | 3 | not attributable |
| PBMG eG | 3 | not attributable |
| AOK Bayern - Die Gesundheitskasse | 2 | not attributable |
| AOK Rheinland/Hamburg - Die Gesundheitskasse | 2 | not attributable |
What they win
Awards
Showing 1–25 of 84 awards we hold
- Germany – Pharmaceutical products – Rabattvereinbarung für das Arzneimittel Exdensur mit dem Wirkstoff Depemokimab ↗AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringenshared awardawarded 29 Jul 2026
- Germany – Pharmaceutical products – 35. Generikaausschreibung (2/3er) - Bekanntmachung vergebener Aufträge ↗GWQ ServicePlus AGshared awardawarded 25 Jul 2026
- Germany – Pharmaceutical products – 35. Generikaausschreibung (2/3er) - Bekanntmachung vergebener Aufträge ↗GWQ ServicePlus AGshared awardawarded 25 Jul 2026
- Aciclovir (CRE) ↗GWQ ServicePlus AGshared awardawarded 24 Jul 2026
- Aciclovir (CRE) ↗GWQ ServicePlus AGshared awardawarded 24 Jul 2026
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2026 und 01.07.2026 ↗PBMG eGawarded 16 Jun 2026
- Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach §130 a Abs. 8 SGB V und §130 c SGB V zu den Präparat mit dem Wirkstoff Depemokimab ↗GWQ ServicePlus AG€1awarded 27 May 2026
- Germany – Pharmaceutical products – Gewährung von Rabatten bei der Abgabe von Fertigarzneimitteln mit dem Wirkstoff Depemokimab (ATC-Code: R03DX12) ↗AOK Sachsen - Anhalt€1awarded 5 May 2026
- Gewährung von Rabatten bei der Abgabe von Fertigarzneimitteln mit dem Wirkstoff Depemokimab (ATC-Code: R03DX12) ↗AOK Sachsen - Anhalt€1awarded 4 May 2026
- Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130a Abs. 8 SGB V i. V. m § 130c Abs. 1 SGB V zum Wirkstoff Depemokimab ↗AOK Baden-Württembergshared awardawarded 29 Apr 2026
- Atorvastatin ↗AOK Baden-Württembergshared awardawarded 15 Apr 2026
- Germany – Pharmaceutical products – Abschluss von Rabattverträgen gemäß § 130a Abs. 8 SGB V für Arzneimittel im generischen Markt ↗AOK Baden-Württembergshared awardawarded 1 Apr 2026
- Germany – Pharmaceutical products – Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der GlaxoSmithKline GmbH & Co. KG zu Exdensur ↗IKK classic€1awarded 24 Mar 2026
- Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der GlaxoSmithKline GmbH & Co. KG zu Exdensur ↗IKK classic€1awarded 24 Mar 2026
- Germany – Pharmaceutical products – Arzneimittelausschreibung 2025_vergebene Aufträge ↗IKK classicshared awardawarded 19 Jul 2025
- 001 | Abirateron Filmtabletten [3] ↗IKK classic€973kawarded 18 Jul 2025
- Vereinbarung gemäß § 130c SGB V zu dem Arzneimittel Nucala mit dem Wirkstoff Mepolizumab ↗AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringenawarded 2 Apr 2025
- Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu dem Wirkstoff Mepolizumab ↗AOK Baden-Württembergshared awardawarded 27 Mar 2025
- § 130c Abs. 1 SGB V Trelegy Ellipta(R) Wirkstoffkombination: Vilanterol, Umeclidiniumbromid und Fluticasonfuroat ATC-Code: R03AL08 ↗AOK Bayern - Die Gesundheitskasseawarded 25 Mar 2025
- Germany – Pharmaceutical products – Arzneimittelvergaben zum 01.01.2025 und 01.07.2025 ↗PBMG eGawarded 10 Mar 2025
- Germany – Pharmaceutical products – 32. Generikaausschreibung (2;3er) - Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 27 Jan 2025
- Germany – Pharmaceutical products – 32. Generikaausschreibung (1er) - Auftragsvergabe ↗GWQ ServicePlus AGshared awardawarded 27 Jan 2025
- Aripiprazol (LSE) ↗GWQ ServicePlus AGshared awardawarded 27 Jan 2025
- § 130 c Abs. 1 SGB V Nucala (R) Mepolizumab ATC-Code: R03DX09 ↗AOK Bayern - Die Gesundheitskasseawarded 23 Dec 2024
- Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu der Wirkstoffkombination Vilanterol und Umeclidiniumbromid ↗AOK Baden-Württembergshared awardawarded 25 Oct 2024
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Glaxosmithkline542 awards · £2.2m
- GLAXOSMITHKLINE, S.A.971 awards
- GlaxoSmithKline Inc.493 awards
- GLAXOSMITHKLINE S.P.A.318 awards
- GLAXOSMITHKLINE, LLC309 awards
- GlaxoSmithKline, s.r.o.100 awards
- GlaxoSmithKline AB80 awards
- GlaxoSmithKline (GSK) SRL45 awards
- GlaxoSmithKline Oy31 awards
- GlaxoSmithKline BV19 awards
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.